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For purpose of this thesis, we use human gene nomenclature. Genes are indicated by 
italicized letters, proteins are indicated by regular letters.  
Abstract 
Dispatched 3 (DISP3), sterol - sensing domain (SSD) – containing protein, is a key focus of 
our laboratory. It was described as a gene regulated by thyroid hormone and its expression 
is mainly localized within neural tissue. Our preliminary data suggested increased DISP3 
expression in medulloblastoma, a highly common pediatric cerebellar tumour, therefore we 
wanted to examine DISP3 role in human cancer cells. 
The aim of this thesis is to perform DISP3 overexpression and downregulation in human 
medulloblastoma cell lines and in mouse neural progenitors and analyse its effect on cell 
proliferation and differentiation. For this purpose, we chose DAOY and D341, human 
medulloblastoma cell lines with low and high expression of DISP3 and mouse multipotent 
neural progenitor cell line, C 17.2, with low DISP3 expression.  
We showed, that DISP3 ectopic expression leads to increase in cell proliferation in both 
DAOY and C 17.2 cells. Next, we examined the ability of C 17.2 cells to differentiate into 
neurons and astrocytes and observed, that cells overexpressing DISP3 reveal delay in 
differentiation, what we proved by analysis of cell specific markers.  
Using CRISPR-Cas9 targeting system, we reduced DISP3 expression within D341 cells and 
observed decrease in their proliferation. Finally, we analysed cell cycle profile of DISP3-
downregulated D341 cells.  









Jedním z hlavních projektů naší laboratoře je výzkum funkce proteinu Dispatched 3 (DISP3). 
Tento protein se řadí do rodiny proteinů obsahujících sterol sensing doménu (SSD). Gen, 
který ho kóduje, byl dříve popsán jako regulovaný thyroidním hormonem a k jeho expresi 
dochází především v neurální tkáni. Naše nepublikovaná data ukazují jeho zvýšenou hladinu 
v meduloblastomech, velice častých nádorech mozečku u nezletilých. Na základě těchto 
zjištění jsme začali studovat roli DISP3 v lidských rakovinných buňkách.  
Cílem této práce je sledovat vliv zvýšené nebo snížené exprese DISP3 na buněčnou 
proliferaci a diferenciaci jednak v lidských buněčných liniích, jednak v myšších neurálních 
progenitorech. Za tímto účelem jsme si vybrali buněčné linie DAOY a D341 pocházející 
z lidských meduloblastomů, které se výrazně liší mírou exprese DISP3, a linii myšších 
neurálních multipotentních progenitorů C 17.2, v nichž je DISP3 exprimován velmi slabě.  
Ukázali jsme, že zvýšená exprese DISP3 v buněčných liniích DAOY a C 17.2 vede ke zvýšení 
buněčné proliferace. Dále jsme diferencovali buněčnou linii C 17.2 do neuronů a astrocytů a 
sledovali, že buňky se zvýšenou expresí DISP3 projevují menší ochotu podstoupit 
diferenciační proces, což jsme následně potvrdili pomocí specifických markerů.  
Za použití CRISPR-Cas9 systému jsme snížili expresi DISP3 v buněčné linii D341 a následně 
ukázali, že tento pokles vede ke snížení buněčné proliferace. Na závěr jsme zanalyzovali 
profil buněčného cyklu v populacích buněk D341 se sníženou expresí DISP3.  
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Dispatched 3 (DISP3) was identified in our laboratory during the screen for thyroid 
hormone-regulated genes. DISP3 protein consists of 13 transmembrane domains and 
belongs to the family of sterol sensing-domain (SSD)-containing proteins (Zikova, Corlett et 
al. 2009).  
 
SSD-containing proteins have distinct roles within cell and organism - they play role in 
cholesterol uptake and transport as well as in cholesterol metabolism regulation. Some 
members of the family are also key players in cell signalling (Kuwabara and Labouesse 
2002). DISP3 protein is localized in endoplasmic reticulum and it is supposed to link thyroid 
hormone regulation with cholesterol metabolism (Zikova, Corlett et al. 2009).  
 
DISP3 is predominantly expressed in the brain and the retina, less in the testis. In my thesis, 
I will focus on its expression in cerebellum, where DISP3 is localized mainly within Purkinje 
cells (Zikova, Corlett et al. 2009). As our preliminary data show, DISP3 expression is elevated 
in medulloblastoma tumour samples, which suggest its role in medulloblastoma formation 
or maintenance.  
 
Medulloblastoma is a highly common pediatric tumour, which arise within cerebellum. 
Medulloblastoma is subdivided into four molecular subgroups, which differ in their cell and 
molecular origin and reveal different prognosis (Samkari, White et al. 2015). It was observed 
that dysregulation of distinct neurodevelopmental processes may lead to formation of 
medulloblastoma (Schuller, Heine et al. 2008, Gibson, Tong et al. 2010) and thus it reveals 
the question whether DISP3 may be also involved in this dysregulation.  
 
In this thesis I ask whether DISP3 dysregulated expression in medulloblastoma cell lines has 
effect on cell proliferation, as it is one of the major properties of cancer cells. In addition, I 
also analyse the effect of DISP3 ectopic expression on neural progenitor cells and their 






2. Literature overview 
 
2.1 Dispatched 3 gene/protein 
 
Dispatched 3 ( DISP3, also known as PTCHD2, KIAA1337 and TRUP 1- Thyroid hormone up-
regulated 1; deposited in Genbank with accession number EU429800) was first 
described by in silico study (Katoh and Katoh 2005). By later screening for novel thyroid 
hormone (T3) -regulated genes performed in our laboratory, DISP3 was found as gene 
regulated by T3 treatment in avian erythroid progenitor cells (Zikova, Corlett et al. 2009). 
Chicken transcript is 4017 bp long and gives rise to the protein consisting of 1338 amino 
acids with molecular weight about 150 kDa. Alignment of the chicken sequence reveals 87% 
of homology and 80 % of identity with mouse form, and 84 % of homology and 78% of 
identity with human form. Topology prediction used to characterize protein structure 
revealed, that DISP3 contains 13 transmembrane domains, five of which form so-called 
sterol sensing-domain (SSD). This domain is situated in N-terminal part of the protein among 
second to sixth transmembrane domains (Figure 2.1). Phylogenetic analysis revealed 
relationship of DISP3 to members of SSD-containing family (Kuwabara and Labouesse 2002), 
in which can be found important players in cholesterol metabolism regulation and 
cholesterol linked signaling (Figure 2.2).  
 
Figure 2.1. Scheme of DISP3 structure. Transmembrane domains are visualized as boxes, 
SSD is in the black colour. The protein is localized in the membrane of endoplasmic 




DISP3 expression was studied in mouse and chicken adult tissues. DISP3 expression in 
chicken was mainly observed in brain, retina, testis and thymus, with less abundancy in the 
spleen and the kidney. In mice, its expression was predominantly situated in the neural 
tissue and only weak expression in the bone marrow and the testis was observed. To 
analyze which cell subtypes reveal DISP3 expression in vivo, immunohistochemical staining 
of the retina and the brain tissue was performed. Its expression was found in inner nuclear 
layer of the retina, specifically in ganglion and bipolar cells of retina. In the brain, DISP3 
reveals expression mainly in hippocampus (region CA1-CA3) and cerebellum (Purkinje cells), 
also with scattered localization within the cortex. (Zikova, Corlett et al. 2009). 
 
2.2 Thyroid hormone regulation of DISP3  
 
Thyroid hormone, secreted by thyroid glands, is an important molecule playing role in 
correct development of many tissues in both pre- and postnatal development, and affecting 
cell proliferation and differentiation. Dysregulation of thyroid hormone signalling may lead 
to many dysfunctions as dwarfism, thyroid cancer or various metabolism abnormalities as 
reviewed in (Cho 2015, Gutleb, Cambier et al. 2016). In vivo analysis performed in our 
laboratory showed thyroid hormone dependent DISP3 down-regulation in chicken ganglion 
cells in the retina, without any perturbation of embryonal development. Further studies 
with different cell lines were performed in vitro. DISP3 expression was found in human 
retinoblastoma, mouse hippocampal progenitor and in Sertoli-like cell lines. Its regulation by 
 
Figure 2.2. Phylogeny tree of DISP3. It reveals close relationship of DISP3 to members of 
SSD-containing family (Zikova, Corlett et al. 2009).  
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thyroid hormone was shown to be different in each cell line, depending on cell origin. While 
thyroid hormone treatment of retinoblastoma increases DISP3 expression more than five 
times, in Sertoli-like cells it causes decrease in DISP3 expression almost three times. It 
shows, that DISP3 expression in different cell types responds to T3 treatment in different 
way (Zikova, Corlett et al. 2009).  
 
Thyroid hormone absence during fetal neurodevelopment results in decrease of cortical 
thickness. Diminished proliferation and increased apoptosis within neuron progenitor cells 
together with cell cycle arrest and changes in transcription were observed. These results 
suggests, that  thyroid hormone is a key regulator of neural progenitor proliferation and 
differentiation (Mohan, Sinha et al. 2012).  Similar effects were observed within cerebellum, 
where T3 transport was disrupted. Decrease of cerebellar cortical thickness was observed as 
well as defects in synapsis formation and axon myelination (Lopez-Espindola, Morales-
Bastos et al. 2014).  
 
 The thyroid hormone can affect cell signalling through cytoplasm, cytosol, nuclear or 
mitochondrial receptors and may function by genomic or non-genomic pathway. In non-
genomic pathway, it transduces signal through cytoplasm integrin receptors to Mitogen-
activated protein kinase (MAPK) and Extracellular regulated kinase 1/2 (ERK1/2) pathway, or 
Phosphatidylinositol-3-kinase (PI3K) pathway regulating cell proliferation and 
differentiation. Genomic pathway of thyroid signalling transduce signal directly to nuclear 
thyroid receptors, which serve in unliganded form as transcriptional repressors or activators 
(Cheng, Leonard et al. 2010, Hammes and Davis 2015). T3 effect was found to be crucial not 
only in developing nervous system, but also in other tissues, such as pancreas or testis as 
reviewed in (Lucas, Nascimento et al. 2014, Mastracci and Evans-Molina 2014, Preau, Fini et 
al. 2015). Mechanism of thyroid hormone regulation of Disp3 was studied in our laboratory. 
We analysed thyroid hormone receptor binding sites within DISP3 genomic locus, however, 





2.3 Potential role of DISP3 in cholesterol metabolism 
2.3.1 DISP3 has effect on cholesterol level in vitro 
When expression of DISP3 was analyzed in tissue and cell subtypes, DISP3 localization in cell 
was found to be restricted to the endoplasmic reticulum and outer nuclear membrane in 
both endogenous and ectopic expression. Because DISP3 protein reveals similarity with 
proteins acting in cholesterol metabolism and transport, and moreover, it contains specific 
SSD, which was found to interact with cholesterol (Nohturfft, Brown et al. 1998), cholesterol 
amount in cells was measured. Compared to control cells, approximately 30% increase in 
cholesterol level in cells ectopically expressing DISP3 was found (Figure 2.3). While in control 
cells cholesterol is mainly located in plasma membrane, in the cells with DISP3 ectopic 
expression cholesterol is localized in the endoplasmic reticulum (ER) and its distribution 
overlaps with DISP3 protein ectopic expression. Furthermore, when cells were transfected 
with DISP3 lacking its SSD, only slight increase in cholesterol amount was observed (Zikova, 
Corlett et al. 2009).  
 
These findings together with its domain phylogeny links DISP3 with SSD-containing protein 
family. Although one subcategory of these proteins is involved in cholesterol-linked 
Hedgehog (HH) signaling, the rest of the proteins act in cholesterol synthesis, regulation of 
cholesterol metabolism or in its transport within cell (Kuwabara and Labouesse 2002).  
 
Figure 2.3. DISP3 overexpression leads to increase of cholesterol amount in the cell 
compared to control – filipin staining of cholesterol (Zikova, Corlett et al. 2009).  
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2.3.2 SSD-containing proteins and cholesterol metabolism 
2.3.2.1 SSD-containing protein family 
The SSD-containing family is a group of transmembrane proteins with different function 
within the cell. They are linked in different ways with the cholesterol molecule and its 
distinct roles in cell metabolism and signaling. The SSD-containing protein family can be 
subdivided into three distinct subgroups, based on their role in the cell. The first group 
contains proteins playing role in cholesterol trafficking and uptake. This group consists of 
Niemann-Pick type C protein 1 (NPC1) and Niemann-Pick type C protein 1 – like 1 (NPC1L1).  
The second group of SSD-containing proteins is involved in cell signaling. Proteins Patched 
(PTC) and Dispatched 1 (DISP1) are key regulators of Hedgehog pathway and are localized 
on plasma membrane. HH molecule is a protein with two posttranslational modifications – 
palmitic acid and cholesterol are bound to the HH molecule. PTC is responsible for signal 
income and DISP1 acts in releasing of HH molecule from the cell.  
The last group of SSD-containing proteins plays role in regulation of cholesterol metabolism 
in the cell. It contains 3-hydroxy-3-methylglutaryl-Coenzyme A (3-HMG-CoA) reductase, the 
key enzyme in cholesterol synthesizing mevalonate pathway and its regulatory protein - 
Sterol response element binding protein (SREBP) cleavage-activating protein (SCAP) 
(Kuwabara and Labouesse 2002).  
2.3.2.2 Cholesterol molecule 
Cholesterol is the key molecule in cell metabolism and structure. It is important constituent 
of the plasma membrane, where it affects membrane properties such as fluidity and rigidity 
or fusion of membrane vesicles. While it may interact with hydrophobic residues of 
membrane components due to its hydrophobic aromatic ring, hydroxyl group at the other 
part of the cholesterol molecule can interact with hydrophilic environment. Although 
cholesterol synthesis takes part mainly in the endoplasmic reticulum, its major location in 
the cell is in the plasma membrane. Thus many ways of cholesterol transport in the cell are 
involved. Cholesterol can be translocated by direct binding to the specific proteins between 
different cellular membranes, or can be transferred by vesicular trafficking in the cell as 
reviewed in (Brown and Goldstein 2009, Wustner and Solanko 2015).  
16 
 
Cholesterol content in the cell may be maintained by its uptake due to its receptors on the 
plasma membrane – Low density lipoprotein (LDL) receptors (Brown, Faust et al. 1975) or 
synthesized by so-called mevalonate pathway (Goldstein and Brown 1990). Both of these 
processes are strictly regulated by cholesterol itself and major regulators comes from SSD-
containing protein family (Brown and Goldstein 2009).  
 
2.3.2.3 Cholesterol synthesis 
The key enzyme in cholesterol synthesis is 3-HMG-CoA reductase, which converts 3-HMG-
CoA to mevalonate. This transmembrane protein is localized in the endoplasmic reticulum 
(Liscum, Cummings et al. 1983, Liscum, Luskey et al. 1983, Liscum, Finer-Moore et al. 1985). 
Its expression and protein turnover is particularly regulated by SREBP/SCAP protein 
complex, because cleavage activation of transmembrane transcription factor SREBP is 
required for its translocation into the nucleus. 
 When cholesterol is present in the cell, SCAP binds with cholesterol molecule and together 
they form complex with SREBP. The complex is localized within the endoplasmic reticulum, 
where SREBP cannot be cleaved. However, if cholesterol amount is low, the cholesterol 
molecule does not bind to SREBP/SCAP complex and both proteins are transported to the 
Golgi apparatus, where SREBP is cleaved and thus activated (Wang, Sato et al. 1994, Sakai, 
Duncan et al. 1996, Duncan, Brown et al. 1997, Sakai, Nohturfft et al. 1997, Nohturfft, 
Brown et al. 1998, Nohturfft, DeBose-Boyd et al. 1999). The cleaved SREBP then translocate 
to the nucleus, where it functions as a transcription factor of many genes involved in 
cholesterol metabolism (Hua, Yokoyama et al. 1993, Yokoyama, Wang et al. 1993).  
Another enzyme, which contains SSD and plays important role in cholesterol synthesis, is 
called 7-dehydrocholesterol reductase (7-DHCR) and it converts cholesterol precursor, 7-






2.3.2.4 Cholesterol uptake 
The process of cholesterol uptake can be both LDL particle dependent and LDL particle non-
dependent. Within the LDL particle-dependent uptake, LDL particles are endocytosed and 
cholesterol transfer inside the endosomal/lysosomal vesicle is dependent on Niemann-Pick 
type C 1 protein (Kwon, Abi-Mosleh et al. 2009). Furthermore, another SSD-containing was 
found to be involved in cholesterol LDL non-dependent uptake into the cell within the 
intestine and was characterized as Niemann-Pick type C 1-like 1 protein (Altmann, Davis et 
al. 2004).  
 
2.3.3 Cholesterol linked disorders and SSD-containing proteins 
Since cholesterol is the key molecule with many important roles in both cell and organism, 
such as constituent of membranes or precursor of several hormones, its proper regulation is 
required. When the regulatory mechanism described above is failing, metabolic or 
developmental disorders affecting mainly neural tissues can occur. Two disorders linked 
with SSD-containing proteins were described, Niemann-Pick disease type C and Smith-
Leimli-Opitz syndrome (SLOS).  
Niemann-Pick disease type C was described as neural disorder (Vanier 2015). This disease is 
caused by mutation mainly in gene NPC1. Molecular effect of this mutation was shown as 
accumulation of cholesterol in late endosomes and lysosomes, because NPC1 is responsible 
for cholesterol efflux in these organelles. In NPC1 null mice, beside neuronal malformation 
increase of cholesterol level was found in neuronal cells, especially in Purkinje cells in 
cerebellum (Lopez, Klein et al. 2011). Similar to Niemann-Pick disease, SLOS is caused by 
mutation in SSD-containing protein and affects cholesterol content in the cell. In SLOS, there 
is mutation in 7-DHCR, which leads to accumulation of cholesterol precursor, however, 
cholesterol itself is lacking in the organism. In contrast to Niemann-Pick disease, in SLOS 
variety of different tissue is affected (Patrono, Rizzo et al. 2000).  
Based on our previous findings that DISP3 affects amount and localization of cholesterol in 
the cell, together with fact that it is expressed mainly in neural tissue, where cholesterol 
content in plasma membrane is even higher than in other tissue, we started to ask whether 
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DISP3 could also play role in neural tissue properties. In my project I focus on DISP3 function 
in neural tissue-derived cell cultures with the aim to understand its role in cell proliferation 
and differentiation.   
 
2.4 DISP3 role in neural tissue proliferation and differentiation 
2.4.1 DISP3 expression in neural tissue 
DISP3 is mainly expressed in the neural tissue and its expression in context of the brain was 
observed in Purkinje cells in cerebellum and in hippocampus within CA1-CA3 region and 
dentate gyrus and also weak expression pattern in cortex (Zikova, Corlett et al. 2009). 
Moreover, high expression level of DISP3 was observed in several brain tumor samples, with 
increased expression mainly in medulloblastoma samples (data not published). These data 
suggested an idea, that DISP3 may regulate cell proliferation within the cell. In this thesis, I 
use human medulloblastoma cell lines – DAOY and D341, to perform overexpression and 
knock-out studies and observe Disp3 role in proliferation regulation. Since not only 
proliferation, but also differentiation plays important role in tumor development and 




Medulloblastoma tumor is a common type of high-grade brain cancer derived from the 
cerebellum. The age of patients suffering this disorder is unfortunately low and prognosis 
remains poor, although therapy approach improved and survival ratio have increased to 
70%. However, common occurrence of metastasis, reaching 30% of patients, reveals poor 
prognosis of this high-risk group. Main treatment approach for medulloblastoma remains 
surgery followed by radiotherapy combined with chemotherapy, which often brings often 
side effects such as dementia, risk of early stroke or metastatic dissemination. Therapeutic 
subdivision of medulloblastoma based on histopathology was established into four groups: 
classic, large cell/anaplastic, desmoplastic/nodular cell and extensive nodularity 
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medulloblastoma (Khatua 2016). DISP3 overexpression was observed across all of these 
subtypes (oncomine.org).  
Furthermore, medulloblastoma was divided into specific subtypes based on the molecular 
classification. Four different classes were established, that diverse in cell origin, tumor 
driving mutations and in its prognosis: Wingless (WNT), Sonic Hedgehog (SHH), subgroup 3 
and subgroup 4. First, WNT group of medulloblastoma, with its almost 100% survival rate 
and non-metastatic manner, reveals activating mutation in WNT canonical pathway leading 
to non-physiological accumulation of β-catenin in the cell nucleus and thus driving tumor 
progression. Immunohistochemistry staining of β-catenin thus could be good prognostic 
marker of this cancer subtype and also inhibition of WNT signaling pathway possible clinical 
approach (Samkari, White et al. 2015). In WNT medulloblastoma group mice model, 
mutation driving tumor progression was described in CTNNB1 gene and its cellular origin 
was determined in dorsal brainstem (Gibson, Tong et al. 2010).  
In contrast, SHH medulloblastoma subclass reveals distinct cellular origin as it was shown, 
that Sonic Hedgehog canonical pathway activating mutations lead to medulloblastoma 
formation in mice (Yang, Ellis et al. 2008) and (Schuller, Heine et al. 2008). Prognosis for SHH 
subtype of medulloblastoma depends on additional risk factors such as p53 mutation or 
SHH-independent amplification of GLI and its accumulation in the nucleus. These additional 
markers significantly lower the survival rate to 20-30% of patients within 5 years. However, 
transgenic mice model for this cancer subtype promise new therapeutic approach as the 
new specific inhibitors are tested.  
Whereas WNT and SHH subgroups are well described, subgroup 3 and 4 are less defined 
with several overlaps. Group 3 has unfortunately very poor prognosis, patients mostly suffer  
metastatic progression and thus are classified as high-risk. Hallmark of subgroup 3 
medulloblastoma is amplification of MYC together with specific genetic aberrations.  
Subgroup 4 of medulloblastoma is the least described subgroup with any further 
classification, main marker of this subgroup is Potassium voltage-gated channel subfamily A 
member 1 protein. Although patients of all ages were diagnosed with medulloblastoma, 
unfortunately subfamily 4 mainly affects children. For further classification of this cancer 
subtype, combination of several immunohistochemistry and FISH molecular markers is 
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needed. Some tumors reveal MYC amplification with then poor prognosis, while other 
subcategory shows loss of chromosome 11 and gain of chromosome 17, revealing low-risk 
properties. Based on poorly defined manner of subgroup 3 and 4 formation, there is no 
promising targeted therapy in contrast with WNT or SHH subgroups, however high-
throughput therapeutic screens are bringing new possibilities (Samkari, White et al. 2015).  
In our laboratory, we focused on DISP3 expression in different brain tumor samples. Analysis 
revealed high expression in medulloblastoma cancer in consistency with previous findings 
(oncomine.org). Comparison of different medulloblastoma patient samples among their 
molecular subtypes revealed expression of DISP3 mainly in subcategory 4, with less 
expression in SHH subcategory (preliminary data, Figure 2.4).  
 
2.4.3 DAOY and D341 cell lines 
In my experiments, we were looking for medulloblastoma cell lines with both high and low 
expression of DISP3 to perform up- and down-regulation studies. In our depository, we had 
DAOY cell line expressing low level of DISP3 (preliminary data). This cell line comes from 
human medulloblastoma sample with categorization to desmoplastic group of 
medulloblastoma tumors. It was derived from 4 years old male brain tumor in 1985, 
however, it reveals loss of Y chromosome in its tetraploid karyotype. It was shown to be 
able to form tumors when xenotransplanted into mice. Although the original cell culture 
 
Figure 2.4. DISP3 immunohistological staining in distinct molecular subgroups of 
medulloblastoma. Subgroup 4 (on the left) reveals higher expression of DISP3 (dark 
colour in the left picture). 
Subgroup 4 Subgroup SHH
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revealed ability to undergo both neuronal and glial differentiation, DAOY cell line  cannot be 
differentiated to glial-like cells anymore (Jacobsen, Jenkyn et al. 1985) and (atcc.org).  
In contrast to DAOY cell line, D341 cells express significantly high level of DISP3 (preliminary 
data), which makes them suitable for down-regulation experiments. D341 cell line was also 
derived from human medulloblastoma samples, from 3,5 years old male patient in 1988, 
and is also able to form tumors after xenotransplantation to mice. These cells grow in 
suspension and are capable of forming spheres. The cell line expresses neuroectodermal 
markers and high amount oncogenic c-MYC, in consistency with common MYC expression in 
human medulloblastoma subtypes (Friedman, Burger et al. 1988). Both these cell lines have 
original doubling time more than 30 hours, specifically DAOY 34 hours and D341 37 hours 
(atcc.org).  
 
2.4.4 Differentiation role in medulloblastoma formation 
It was observed that medulloblastoma arise within neural progenitor subpopulation 
(Schuller, Heine et al. 2008). Hence, it is not so surprising to find neural stem properties 
among different tumor samples. During analysis of several pediatric brain tumors was found 
that medulloblastoma maintain stem-like properties when cultured in vitro, where it forms 
neurospheres. These derived cells are still repeatedly able to form tumors after 
xenotransplantations to mice. Moreover, with different success, they are also capable of 
differentiation to neuronal and glial cell subtypes, suggesting idea, that tumor progression in 
this cancer involves block of differentiation and the maintaining stem-like properties 
(Hemmati, Nakano et al. 2003, Singh, Clarke et al. 2003). Therefore, we decided to test 
abilities of DISP3 to affect differentiation of cerebellar neural progenitor cells. 
 
2.4.5 Neurogenesis in cerebellum 
Cerebellum is part of the brain, which is responsible for sensor and motoric activity. 
Moreover, it also plays cognitive role affecting several key functions such as speech, 
attention or emotional behaviour. The cerebellum consists of limited number of cell types, 
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which are localized in specified layers. In the developed cerebellum, there is established 
architecture of tissue consisting of molecular and granule layers, Purkinje cells monolayer 
and cerebellar nuclei neurons zone. Most subpialy, there is localized molecular layer 
consisting of dendritic trees of Purkinje cells together with axon fibres of granule cells. It is 
separated from granule layer, where bodies of granule cells are localized, by monolayer of 
Purkinje cells. At the bottom, there are localized cerebellum nuclei neurons (Marzban, Hoy 
et al. 2015).  
 Neurogenesis in the cerebellum is localized in two distinct zones called ventricular zone and 
rhombic lip, which give rise to distinct cellular subtypes. While ventricular zone produces 
GABAergic neuronal populations, rhombic lip gives rise to glutamatergic neurons. 
Ventricular zone of the cerebellum, in consistency with cortical ventricular zone of 
neurogenesis, produces neural progenitors, which migrate radially through cerebellum body 
and give rise to Purkinje cells and stellate, basket, Golgi and Lugaro interneurons (Butts, 
Chaplin et al. 2011). During cortical neurogenesis, there are neural stem cells in ventricular 
zone, producing radial glia by asymmetrical division. Radial glia were also shown to be 
capable of differentiation to both neuronal or glia cell subtypes.  Radial glia migrate to 
subventricular zone, where they undergo further asymmetrical or symmetrical division to 
increase the number of intermediate neural progenitors. Those cells then give rise to 
mature neurons or glia (Laguesse, Peyre et al. 2015). Cerebellar ventricular zone 
neurogenesis was suggested to bear similar features as cortical neurogenesis, however 
exact mechanism has yet to be elucidated.  
The second zone of cerebellar neurogenesis was defined as rhombic lip, which produces 
neuronal subtypes such as granule cells or unipolar brush cells. Within rhombic lip, there are 
temporaly distinct ways of neurogenesis giving rise to different cell populations. First, 
progenitors of deep nuclei cells are produced, then they migrate tangentially and subpialy 
and then they radially transverse to deep cerebellar nuclei zone. Second, neurogenesis of 
rhombic lip gives rise to granule cells precursors, which also migrate tangentially above pial 
surface. Afterwards, granule cell precursors undergo massive proliferation to form so-called 
external germinal layer (EGL). Proliferation in EGL is caused by SHH signal, which is produced 
by already established Purkinje cells layer. It was suggested that dysregulation of this 
mechanism leads to medulloblastoma formation. At last, rhombic lip neurogenesis produce 
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unipolar brush cell precursors, which also migrate to external germinal layer, where the 
both precursors undergo differentiation and migration to their specified localization in the 
granule layer. Although all these mechanism starts early in embryogenesis, definitive 
formation of cerebellar architecture is finished postnataly, human cerebellum architecture is 
established during first two years (Butts, Chaplin et al. 2011).  
 
2.4.6 C 17.2 cells and their differentiation 
In my experiments, I use mouse neural progenitor cells C 17.2 to observe their 
differentiation upon DISP3 overexpression. C 17.2 cells were derived from cerebellar 
external germinal layer, which makes them good model for experiments studying DISP3 
effect on differentiation properties. C 17.2 cells were derived by retroviral transduction of v-
myc in dissociated mice cerebellum cells. After selection, several clones were tested for 
their properties. C 17.2 clone was described as cell line capable of differentiation to neuron-
like and glia-like cell subtypes with ability to be transplanted to developing cerebellum 
(Snyder, Deitcher et al. 1992). In in vitro conditions, C 17.2 cells are capable of 
differentiation to neurons and astrocytes when treated with N2 supplement, brain-derived 
neurotrophic factor (BDNF) and nerve growth factor (NGF) (Lundqvist, El Andaloussi-Lilja et 
al. 2013). 
 To prove differentiation to distinct neural cell subtypes, specific biomarkers are used, on 
both mRNA and protein levels. Neural progenitors are commonly characterized by 
production of Nestin, type IV intermediate filament (Frederiksen and McKay 1988, 
Dahlstrand, Lardelli et al. 1995). Neurons are defined by expression of a cytoskeletal 
protein,  β-III tubulin, that is localized in axons and dendrites of neuron, although it is 
produced in neuron body (Roskams, Cai et al. 1998). Finally, to detect astrocytes, Glial 
fibrillary acidic protein (GFAP), cytoskeletal protein from the type III intermediate filament 





3. Materials and Methods 
3.1 Materials 
3.1.1 Vectors and constructs 
pBabe - Hygro - Disp3 
pBABE-Hygro (Plasmid No. 1765 – AddGene) is retroviral expressing vector with hygromycin 
resistance. The full length human DISP3 cDNA was cloned to the pBABE-Hygro vector and 
the construct was called pBabe-Hygro-DISP3. It was obtained from M. Zikova, Ph.D. and 
used for over-expression experiments. 
 
pCDNA3 - DISP3 
pCDNA3 is mammalian expressing vector with neomycin resistance. The full-length human 
DISP3 cDNA was cloned to the pCDNA3 vector and the construct was called pCDNA3-DISP3. 
It was obtained from M. Zikova, Ph.D. and used for over-expression experiments.  
 
pGEM-T Easy Vector System I 
pGEM-T is linearized vector with thymidine overhangs used to subclone of PCR products 
(Promega).  
 
pLentiCRISPR-Loop1.1, -Loop1.2, -Loop1.3, Loop1.4, -SSD4, -SSD5 
pLentiCRISPRv1 (Plasmid No. 49535 - AddGene) is vector with puromycin resistance, 
expressing Cas9 enzyme and CRISPR gRNA (Shalem, Sanjana et al. 2014). Different 
oligonucleotides (Loop1.1, Loop1.2, Loop1.3, Loop1.4, SSD4 and SSD5) were cloned into the 
pLentiCRISPRv1 as templates for CRISPR gRNA expression and these constructs were called 
pLentiCRISPR-Loop1.1, pLentiCRISPR-Loop1.2, pLentiCRISPR-Loop1.3, pLentiCRISPR-Loop1.4, 






Vector pCMV-VSV-G (Plasmid No. 8454 – AddGene) encodes envelope proteins for lentiviral 




Vector psPAX2 (Plasmid No. 12260 – AddGene) encodes packaging proteins of lentiviral 
particle. Used in co-transfection with pCMV-VSV-G and pLentiCRISPR constructs to prepare 
lentiviral particles.  
 
3.1.2 Enzymes 
Restriction enzymes, DNA ladder and T4 ligase used for work with recombinant DNA were 
obtained from Promega, New England Biolabs and Fermentas.  
 
3.1.3 Bacteria and growing media 
Bacteria: Escherichia coli strain TOP 10 (Invitrogen), fast growing strain used for 
amplification of plasmids.  
LB medium: 1% tryptone, 1% yeast extract, 1% NaCl 
LB agar: 1.5% agar in LB 
Selective antibiotics:  





3.1.4 Eucaryotic cell lines 
HEK Phoenix-ECO 
Human embryonic kidney adherent cell line used for retroviral particles packing. Cell line 
already contains Adeno- and SV40 viral sequences (ATCC® CRL-3214™).  
HEK 293 FT 
Human embryonic kidney adherent cell line with stable expression of SV40 large T antigen. 
It is used for lentiviral particles production.  
C 17.2  
Mouse adherent neural progenitor cell line, derived from cerebellar tissue (Snyder, Deitcher 
et al. 1992).  
DAOY 
Human medulloblastoma cell line (ATCC® HTB-186™). 
D341 
Human medulloblastoma cell line (ATCC® HTB-187™).  
 
 
3.1.5 Media and reagents for eukaryotic cells 
Reagents:  
Dulbecco's Modified Eagle Medium (DMEM), Gibco ref. 11885-084 
Improved Minimum Essential Medium (Improved MEM), Gibco ref. 10373-017 
DMEM Nutrient Mixture F-12 HAM (DMEM:F12), Sigma-Aldrich ref. D8062 
Fetal Bovine Serum (FBS), Gibco ref. 10270-160 
Horse Serum (HS), Gibco ref. 26050088 
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Normal Goat Serum (NGS), Gibco ref. PCN5000 
L-Glutamin, Gibco ref. 25030-024 
Penicilin/Streptomycin mixture (P/S), Gibco ref. 15140-122 
N2 Supplement, Gibco ref. 17502-048 
Brain-derived neurotrophic factor (BDNF), R&D Systems ref. 248-BD-005 
Nerve growth factor (NGF), R&D Systems ref. 1156-NG-100 
Opti-MEM, reduced serum medium, Gibco ref. 11058021 
Lipofectamine®2000 Reagent, Invitrogen ref. 11668019 
Geneticin (G418), Thermo Fisher Scientific, ref. 10131027, 200-350 µg/ml 
Puromycin, Thermo Fisher Scientific, ref. A1113803, 300 ng/ml 
 
Media:  
HEK Phoenix-Eco and HEK 293 FT 
DMEM, 10% of FBS, 2% L-Glutamin, 1% P/S 
C 17.2 
DMEM, 10% FBS, 5% HS, 1% L-Glutamin, 1% P/S, 7 ml Glucose (25%) 
C 17.2 differentiating medium 
DMEM:F12, 1% N2 supplement, 10 ng/ml BDNF, 10 ng/ml NGF 
DAOY, D341 





3.1.6 CRISPR gRNA oligonucleotides 
Target sequences were selected by http://www.e-crisp.org/E-CRISP/ webpage, 
complementary sequences were then designed and BsmBI overhangs were added. 
Oligonucleotides with BsmBI overhangs were ordered, annealed and cloned into 
pLentiCRISPR vector. All designed oligonucleotides were obtained from Sigma-Aldrich.  
Loop1.1: 
5‘- CACCGAAGCGTCTCGGAGGTGAAGT – 3‘ and 5‘- AAACACTTCACCTCCGAGACGCTTC – 3‘ 
Loop1.2: 
5‘-CACCGCTGCCAGATCCTCCAGGGGC – 3‘ and 5‘-AAACGCCCCTGGAGGATCTGGCAGC – 3‘ 
Loop1.3: 
5‘-CACCGTTGCTCAGCCGCTGGTTTCG – 3‘ and 5‘-AAACCGAAACCAGCGGCTGAGCAAC – 3‘ 
Loop1.4:  
5‘-CACCGGGTAGACTGCTTGGCCAGCA – 3‘ and 5‘-AAACTGCTGGCCAAGCAGTCTACCC – 3‘ 
SSD4:  
5‘-CACCGAGCTGCTGCTGATGAAGGCC – 3‘ and 5‘-AAACGGCCTTCATCAGCAGCAGCTC – 3‘ 
SSD5:  









3.1.7 Primers  
All primers were designed by http://www.ncbi.nlm.nih.gov/tools/primer-blast/ webpage 
and obtained from Sigma-Aldrich.  
The following primers were used for T7 endonuclease assay and sequencing: 
Loop1.1:  
FW: 5´-TACTACCCACCGCTGGACAT-3´ and RV: 5´-TTTCGCGGGTCTTCACTCTG-3´ 
Loop1.2, Loop1.3:  
FW:5´- CTTCACCTCCGAGACGCTT-3´ and RV:5´- AGTAGGTCATGAGCGAGCTG-3´ 
Loop1.4:  
FW:5´- GGCTGCAATGAGACTGGATG-3´ and RV: 5´-TGTCAGAGAGACTGCAAGGATG-3´ 
SSD4:  
FW:5´- TTGGCCATAGATATGGAGAATTGGA-3´ and RV:5´- GGCTCAAGAGTATTGCAGCAT-3´ 
SSD5: 
FW:5´- GCTGGGAACAGAGTGGTGAA-3´ and RV:5´- GCTCCTCCCACCAAGAGTTC-3´ 
 
The following primers were used for RT-PCR and qRT-PCR:  
Ubiquitin: FW: 5´-ATGTGAAGGCCAAGATCGGAG-3´ and RV: 5´-TAATAGCCACCCCTCAGACG-3´ 
GAPDH: FW: 5´-CCATGACAACTTTGGCATTG-3´ and RV: 5´-TCCCCACAGCCTTAGCAG-3´ 
DISP3: FW: 5´-CAGCAGTTTGACCTCTTCA-3´and RV: 5´-GCAACATCTGCAGGAAGGA-3´ 
Nestin: FW: 5´-AGGCTGAGAACTCTCGCTTGC-3´ and RV: 5´-GGTGCTGGTCCTCTGGTATCC-3´ 
βIII-tubulin: FW: 5´-TGGACAGTGTTCGGTCTGG-3´and RV: 5´-CCCTCCGTATAGTGCCCTTTG-3´ 
GFAP: FW: 5´-TGAGGCAGAAGCTCCAAGA-3´and RV: 5´-CCAGGGTGGCTTCATCTGC-3´ 
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3.1.8 Immunostaining antibodies 
Primary antibodies 
DISP3: Rabbit polyclonal anti-DISP3 antibody, 1:400, obtained from M. Zikova, Ph.D. 
GAPDH: Mouse monoclonal anti-GAPDH antibody, used as marker,1:2000,  
GeneTex ref. GTX627408 
Nestin: Monoclonal anti-nestin mouse antibody, clone rat-401, 1:400, 
EMD Millipore ref. MAB353 
β-III tubulin: Monoclonal mouse neuron-specific β-III tubulin antibody, 1:1000,  
R&D Systems, ref. MAB1195 
GFAP: Mouse monoclonal glial-specific anti-GFAP antibody, 1:400, Sigma-Aldrich ref. G3893 
 
Secondary antibodies – immunoblotting 
Anti-rabbit IgG, peroxidase-linked antibody, GE Healthcare ref. NA9340 
Anti-mouse IgG, peroxidase-linked antibody, Cell Signaling Technology ref. 7076S 
SuperSignal™ West Pico Chemiluminescent Substrate, Thermo Scientific ref. 34087 
 
Secondary antibodies – immunofluorescence 
Anti-Mouse IgG, Secondary Antibody, Alexa Fluor® 488:  
Used for staining of mouse primary antibodies, visible in green, Invitrogen ref. A11029 
Anti-Mouse IgG, Secondary Antibody, Alexa Fluor® 568:  




Anti-Rabbit IgG, Secondary Antibody, Alexa Fluor® 488:  
Used for staining of primary rabbit antibodies, visible in green, Invitrogen ref. A11034 
Anti-Rabbit IgG, Secondary Antibody, Alexa Fluor® 568:  
Used for staining of rabbit primary antibodies, visible in red, Invitrogen ref. A11036 
 
3.1.9 Buffers and solutions 
1xPBS: 150 mM NaCl, 1.5 mM KH2PO4, 2.7 mM Na2HPO4, pH 7.4 
1xTAE: 40 mM Tris, 40 mM acetic acid, 1 mM EDTA, pH 8.0 
Phenol-chloroform solution: 1:1 volumes; phenol equilibrated by 0.1 M Tris pH 8.0 
Polyethylenimine (PEI): 1 mg/ml solution in water; sterilized by filtration through 
0.22 µm filter. 
1x Trypsin: 0.05 % trypsin, 0.02 % EDTA 
TEG: 25 mM Tris pH 8.0, 10 mM EDTA pH 8.0, 50 mM glucose 
Lysis buffer: 0.2 M NaOH, 2% SDS 
Neutralization buffer: 3 M K+, 5 M Ac- 
Phenol-chloroform solution: 1:1 of both volume; phenol equilibrated by 0.1 M Tris pH 8.0 
1M Tris: 12.1 g of Tris base dissolved in 100 ml of deionized water 
1 × Sample buffer (1x SB): 63 mM Tris HCl, 10% Glycerol, 2% SDS, pH 6.8 
1× TGS buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3 
1 × TG buffer: 25 mmol/l Tris, 192 mmol/l glycine, pH 8.3, buffer contained 20% methanol 
1x TBS buffer: 50 mM Tris HCl, 150 mM NaCl, pH 7,5 
1x TBST buffer: 1xTBS, 0,05% Tween-20 
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3.1.10 Proliferation assay materials 
[methyl-3H]-Thymidine, Moravek Biochemicals and Radiochemicals ref. MT6034 
MultiLexTMA, Perkin Elmer ref. 1450-441 
Filtermat A, Perkin Elmer ref. 1450-421 
FilterMate Harvester, Perkin Elmer 
Proliferation assays were evaluated by 1450 MicroBeta, Perkin Elmer.  
 
3.1.11 Other materials 
ProLong® Gold Antifade Mountant with DAPI, Life Techologies ref. P36941 
Bovine Serum Albumin, Sigma-Aldrich ref. A2153 




3.2.1 Nucleic acids work 
Nucleic acid quantification 
Concentration and quality of nucleic acids (both RNA and DNA) was measured by Nanodrop 
ND 1000.  
 
Oligos annealing 
1. Annealing mix (1µl of 100µM solution of both oligos, 1 µl of 10x NEB T4 Ligation 
Buffer, 6,5 µl of ddH2O and 0,5 µl of NEB T4 PNK) was prepared.  
2. The mix was incubated for 30 minutes at 37°C.  
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3. The mix was heated up to 95°C, then temperature ramped down to 25°C 
(5°C/minute). 
4. Annealed oligos were diluted in nuclease free water in ratio 1:200 of oligos to water. 
 
Restriction enzyme digestion 
Conventional enzymes were used for digestion according to the protocol. Typically,          
200-500 ng of plasmid DNA was used for digestion by 0,5 µl of enzyme in specific buffer. 
Reaction was stopped by heat inactivation at 95°C, or by addition of EDTA. 
 
Agarose Gel Electrophoresis 
Typically, it was used 0,8% - 1,5% (according to the fragment size) solution of agarose in 
TAE. Ethidium bromide (1:10000) was added and solution was gently mixed. Voltage was 
normally set up to maximally 9V/cm. Samples were mixed with 6x DNA Loading Dye 
(Thermo Scientific, ref. #R0611). DNA ladders were used according to the fragment size – 
100bp DNA Ladder (BioLabs, ref. #N3231S) and Gene Ruler 1kb Plus (Thermo Scientific, ref. 
#R0611).  
DNA extraction from agarose gel 
QIAEX II Gel Extraction Kit 
Reagents:   
QIAEX II suspension: silica-gel particles 
Buffer QX1: used for solubilization of agarose and binding of DNA to silica particles, it 
removes residual agarose 






1. Desired DNA fragment was excised from the gel.  
2. Three volumes of QG Buffer were added to 1 volume of gel fragment. The mix was 
incubated for 10 minutes at 50°C. The tube was eventually vortexed.  
3. Isopropanol (1 volume of gel slice) was added and vortexed.  
4. The gel solution was placed to the column. Column was centrifuged for 1 minute at 
13 000 rpm (Eppendorf 5415R) and supernatant was discarded. 
5. Column was washed with PE Buffer (750 µl).  
6. DNA was eluted from the column by addition of nuclease free water (Ambion), water 
was eluted to the new tube by centrifugation.  
 
T4 ligation 
Normally, it was used 50 ng of backbone vector DNA and insert in 3:1 molar excess. Ligation 
was performed in 10 µl solution, with 1 µl of T4 Ligase (Fermentas) and 1 µl of 10x T4 Ligase 
Buffer (Fermentas). The ligation was performed at RT for 1 hour and whole amount of 




pGEM T Easy Vector System I 
pGEM vector is pre-linearized plasmid with thymidine overhangs for easier subcloning of 
PCR product (polymerase adding adenine overhangs needs to be used).  
Usually, for one reaction we used 50 ng of pGEM with 3:1 molar excess of PCR product.      
T4 ligase (1 µl, included) and 10x reaction buffer (1 µl, included) were added to 10µl 
reaction. Reaction mix was incubated for 16-18 hours at 4°C followed by 1 hour at RT. pGEM 
vector bears lacZ gene, that enables X-Gal blue/white selection, and T7 and SP6 sequencing 





Normally, we added 5 µl of 5µM solution of specific primers (see above) to 500 ng of 
plasmid DNA diluted in nuclease free water in total amount 10 µl. Sequencing was ordered 
from SEQme s.r.o. company and sequences were obtained in FASTA file.  
 
Genomic DNA isolation 
QIAamp® DNA Minikit 
Reagents:  
AL Buffer: used for cell lysis.  
AW1 Washing Buffer: used to remove impurities from the DNA.  
Proteinase K (20 mg/ ml): used to avoid protein contamination in isolated DNA.  
Procedure:  
1. The cells were harvested and resuspended in 200 µl of PBS, 20 µl of Proteinase K was 
added as well as 200 µl of AL Buffer.  
2. The mixture was incubated at 56°C for 10 minutes and eventually vortexed.  
3.  Ethanol (200 µl, 96%) was added and tube was vortexed for 15 seconds.  
4. The mix was placed into the column. It was centrifuged for 1 minute and 8 000 rpm 
(Eppendorf 5415R) and the supernatant was removed.  
5. AW1 Washing Buffer (500 µl) was added and centrifuged for 3 minutes and 13 000 
rpm.  
6. The supernatant was removed and the column was centrifuged again for 1 minute 
and 13 000 rpm.  
7. It was added 200 µl of nuclease free water to the column and incubated for 5 
minutes at RT. 
8. The column was centrifuged for 1 minute and 8 000 rpm – supernatant contained 




RNA isolation  
1. The cells were lysed by Trizol Tri Reagent (BioTech, ref. TR118) and the lysate was 
incubated for 10 minutes at 4°C – 1ml of Tri Reagent per 3cm dish of cells.  
2. The lysate was centrifuged for 10 minutes and 13 000 rpm (Eppendorf 5415R) and 
the supernatant was replaced to the new tube.  
3. Chloroform (200 µl) was added and intensively vortexed for 30 seconds.  
4. The mixture was incubated for 15 minutes at 4°C and then centrifuged for 15 
minutes and 13 000 rpm.  
5. Upper phase was transferred to the new tube and isopropanol (450 µl) was added.  
6. The mixture was incubated for 16-18 hours at -20°C and centrifuged for 10 minutes 
and 13 000 rpm. The supernatant was removed.  
7. The pellet was washed twice with 75% ethanol, centrifuged for 5 minutes and 13 000 
rpm and the supernatant was removed.  





Whole procedure was performed at nuclease free conditions and at 4°C and all reagents 
were obtained from Promega.  
Usually, RNA (1 µg) was diluted in nuclease free water in total volume of 8 µl. 10x DNase 
Buffer (1µl) and DNase (1 µl) were added. The reaction was incubated at 37°C for 30 







 Whole procedure was performed at nuclease free conditions and at 4°C. All the reagents 
were obtained from Promega.  
1. RNA (1µg) was diluted in 14,5 µl of nuclease free water and 0,5 µl of Random 
Primers was added.   
2. The mix was incubated at 70°C for 5 minutes and then at 4°C for 5 minutes.  
3. RT premix (2,5 µl of 10x M-MLV RT Buffer, 1 µl of 12,5mM dNTP, 0,5 µl of RNasin and 
5 µl of nuclease free water) was added to RNA solution. 
4. M-MLV Reverse Transcriptase (1 µl) was added to the reaction.  
5. The mixture was incubated for 1 hour at 37°C.  
6. The reaction was stopped by incubation at 95°C for 2 minutes.  
 
PCR – T7 Endonuclease assay, subcloning 
PCR premix (1 µl of 4mM dNTP - Thermo Scientific, 0,5 µl of 10 mM FW primer, 0,5 µl of 10 
mM RV primer,2 µl of 10x Taq Polymerase Buffer – BioLabs, and 0,3 µl of Taq Polymerase – 
BioLabs) was prepared. The template DNA (50 – 200 ng) was diluted in nuclease free water 
in total volume of 15,7 µl and the solution was mixed with PCR premix. 
PCR cycle was performed in following conditions:  
1. Initial denaturation was performed at 94°C for 3 minutes.  
2. Cyclic denaturation was performed at 94°C for 30 seconds.  
3. Primer annealing was performed according to specific primers. Normally, 
temperature varied in between 59-60°C for 50 seconds. 
4. Extension was performed according to the length of amplified fragment – 1 minute 
of extension time per 1 kb of DNA fragment. Temperature was set up at 72°C.  
5. Final extension step was performed at 72°C for 10 minutes.  
6. At the end, temperature ramped down to 10°C.  
Step 2 to 4 were repeated in cycle. Number of repeat varied in between 28 to 34.  
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PCR product phenol-chloroform extraction 
This procedure was used for PCR product cleaning, mainly for T7 Endonuclease assay.  
1. PCR product was diluted in water in total amount 225 µl.  
2. NaAc solution (final concentration 0,5M) was added to PCR product and 250 µl of 
phenol/chloroform (1:1) mixture was added.  
3. The mix was intensively vortexed and centrifuged for 3 minutes and 13 000 rpm 
(Eppendorf 5415R).  
4. Upper phase was transferred to the new tube and 250 µl of chloroform was added.  
5. The mixture was intensively vortexed and centrifuged for 3 minutes and 13 000 rpm. 
6. The supernatant was transferred to the new tube and 250 µl of isopropanol was 
added.  
7. The mixture was intensively vortexed and centrifuged for 10 minutes and 13 000 
rpm, the supernatant was removed.  
8. The pellet was washed by addition of 250 µl of 75% of ethanol. Centrifuged for 5 
minutes and 13 000 rpm.  
9. The supernatant was removed and the liquid was dried. 
10. The pellet was resuspended in desired amount of nuclease free water.  
qRT – PCR 
For qRT-PCR procedure, the amount of RNA used for Reverse Transcription was 200 ng and 
Reverse Transcription product was diluted in nuclease free water in 1:1 ratio, this solution 
was then used as template for qRT-PCR reaction.  
Reaction mix (2,5 µl of Light Cycler® SYBR Green Master, Roche, 1 µl of mix of 10mM FW 
and RV primers, 0,5 µl of nuclease free water and 1 µl of DNA template) was prepared.  
The reaction was performed on Light Cycler®480 (Roche) and evaluated by its software.  
PCR cycle was performed in following conditions:  
1. Initial denaturation was performed at 95°C for 3 minutes.  
2. Denaturation was performed at 95°C for 15 seconds.  
3. Annealing of primers was performed at 61°C for 20 seconds.  
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4. Extension was performed at 72°C for 15 seconds.  
5. Final extension was performed at 72°C for 3 minutes.  
6. At the end, temperature ramped down to 4°C.  
Steps 2 to 4 were repeated in 44 cycles.  
 
T7 Endonuclease assay 
Genomic DNA, isolated from the cells, was followed by PCR reaction and PCR product was 
cleaned up as described above. Primers were designed asymmetrically with respect to the 
CRISPR target site, to obtain bands with different size on gel electrophoresis after T7 
endonuclease digestion.  
1. DNA (200 ng) was diluted in nuclease free water and proper concentration of 
NEBuffer 2 (NEB) in total volume of 19 µl.  
2. The mix was incubated at 95°C for 5 minutes and temperature then ramped down - 
from 95-85°C with rate 2°C per second, from 85-25°C with rate 0,1°C per second. 
3. T7 Endonuclease (1 µl, NEB) was added to the mix and incubated for 20 minutes at 
37°C.  
4. The reaction was then stopped by addition of 0,25M EDTA (1,5 µl) and evaluated by 




3.2.2 Bacterial work 
X-Gal plates preparation 
Mix: The mix (40 µl X-Gal, 100 µl 10mM IPTG and 100 µl LB) was equally spread to LB plate 





1. Competent bacteria (100 µl) were thaw on the ice. 
2. Ligation mix (5 µl) or plasmid DNA (1 µl) was added to the cells and gently mixed. 
The mix was incubated on the ice for 10 minutes. 
3. Bacterial mix was incubated for 1 min at 42°C.  
4. The mix was quickly cooled down and incubated for 10 minutes on the ice.  
5. LB medium (750 ml) was added and the whole mix was incubated for 45 minutes at 
37°C and constantly shaking for 270 rpm.  
6. The tube was centrifuged for 5 min and 6500 rpm (Eppendorf centrifuge 5415 R). 
7. Supernatant was removed and the pellet was resuspended in the fresh LB medium 
(100 µl). 
8. Bacteria were spread on the plate containing antibiotics according to the plasmid 
resistance. Plates were cultivated at 37°C for 12-18 hours. 
 
Plasmid DNA isolation:  
“Miniprep” isolation 
1. Desired colonies from LB plate were picked up and cultivated in 2 ml of LB medium 
with antibiotic according to the plasmid resistance – at 37°C and 270 rpm for 16-18 
hours.  
2. The culture was centrifuged for 5 minutes and 13 000 rpm.   
3. The pellet was resuspended in 50 µl of TEG buffer.  
4. Lysis buffer (50 µl) was added to the bacterial mixture and the mix was incubated at 
room temperature (RT) for 5 minutes.  
5. Neutralisation buffer (50 µl) was added and the tube was vortexed. 
6. Phenol/chloroform solution (150 µl) was added and the tube was vortexed 
intensively.   
7. The sample was centrifuged for 5 minutes and 13 000 rpm.  
8. Upper phase (125 µl) was replaced to the new tube and isopropanol (125 µl) was 
added. The tube was vortexed intensively.  
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9. The sample was centrifuged for 10 minutes and 13 000 rpm.  
10. Supernatant was removed and 500 µl of 75% ethanol was added.  
11. The sample was centrifuged for 5 minutes and 13 000 rpm.  
12. Supernatant was removed and the pellet was dried.   
13. The pellet was resuspended in nuclease free water (Ambion).  
 
“Midiprep” isolation 
JetStar® 2.0 Plasmid Purification Kit 
Reagents:  
Cell resuspending buffer (E1): 50 mM Tris-HCl, pH 8.0, 10 mM EDTA, RNase A in final 
concentration 100 µg/ml 
Lysis buffer (E2): 0.2 M NaOH, 1% (w/v) SDS 
Precipitation buffer (E3): 3.1 M Potassium acetate, pH 5.5 
Equilibration buffer (E4): 0.1 M Sodium acetate, pH 5.0, 0.6 M NaCl, 0.15% (v/v) TritonX-100 
Wash buffer (E5): 0.1 M Sodium acetate, pH 5.0, 0.8 M NaCl 
Elution buffer (E6): 0.1 M Tris-HCl, pH 8.5, 1.25 M NaCl 
RNase A: 20 mg/mL in 50 mM Tris-HCl, 10 mM EDTA, pH 8.0 
 
  Procedure:  
1. E4 buffer (10 ml) was added and let drain by gravity flow to equilibrate the column.  
2. Overnight bacterial culture (50 ml) was centrifuged for 5000 g and 10 minutes and 
the supernatant was removed.  




4. E2 buffer (4 ml) was added, gently mixed until it was homogenous and incubated for 
5 minutes at RT.  
5. E3 buffer (4 ml) was added, gently mixed until it was homogenous and centrifuged 
for 5000 g for 30 minutes.  
6. The supernatant was loaded to the equilibrated column and let drain by gravity flow.  
7. Column was washed twice with E5 buffer (10 ml). Buffer was let to drain by gravity 
flow. 
8. The column was replaced to clean tube and E6 buffer (5 ml) was added and let drain 
by gravity flow.  
9. Isopropanol (3,5 ml) was added and the mixture was mixed. It was centrifuged for 
5000 g and 30 minutes at 17°C.  
10. The supernatant was removed and the pellet was resuspended in 1 ml of 75% 
ethanol until it was homogenous. The whole mixture was replaced to 1,5ml tube.  
11. The sample was centrifuged for 5 minutes and 13 000 rpm (Eppendorf 5415 R).  
12. The supernatant was removed and the pellet was dried. Afterwards, it was 
resuspended in 50 µl of nuclease free water (Ambion).  
 
3.2.3 Eukaryotic cell work 
Adherent cell lines cultivation 
All of the cell lines were cultured in 5% carbon dioxide atmosphere at 37°C.  
HEK Phoenix-Eco, HEK 293 FT, DAOY and C 17.2 cells were cultured adherently on the dish 
(TPP) with 60-90 % of confluency. Cells were subcultured every second-third day.  
Adherent cell lines subculturing 
1. Culture medium was removed from the dish. 
2. Cells were washed with PBS buffer.  
3. Trypsin solution was added to cells and cells were incubated for 5 minutes at 37°C.  
4. Cell suspension in trypsin solution was replaced to the tube and adequate volume of 
growing media was added.  
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5. The tube was centrifuged for 3 minutes at 120 g.  
6. Supernatant was discarded and the pellet was resuspended in desired amount of 
fresh medium.   
7. Cell suspension was transferred onto new plastic dish.  
 
Spheroid cell line cultivation 
D341 cells were cultured in 5% carbon dioxide atmosphere at 37°C in spheroid suspension in 
cultivation flask (Greiner). Cells were subcultured every second-third day.  
 
Spheroid cells subculturing 
1. Cell suspension was collected into the tube. 
2. Adherent subpopulation of cells was washed with PBS (1x). Cells in PBS were 
transferred into the tube. 
3. Trypsin solution was added and cells were incubated at 37°C for 5 minutes.  
4. Cell suspension in trypsin solution was transferred to the tube.  
5. The tube was centrifuged for 3 minutes and 120 g.  
6. Supernatant was discarded and pellet was resuspended in desired amount of 
growing medium. 
7. Cell suspension was transferred into new flask.  
 
C 17.2 cells differentiation  
1. Cells were seeded with 50% confluency on the dish.  
2. Next day (day 0) the growing medium was changed for differentiating medium.  
3. Day 3 change of medium for fresh differentiating medium.   






1. Cells were seeded day before to be 90% confluent in the day of transfection, 10cm 
dish size was normally used for transfection.   
2. Mix of 500 µl of Opti-MEM and 10 µg of plasmid DNA was prepared. 
3. Mix of 480 µl of Opti-MEM and 20 µl of Lipofectamine was prepared. 
4. Both mixtures were incubated for 5 minutes at RT and gently mixed continuously. 
5. Lipofectamine/Opti-MEM and DNA/Opti-MEM mixtures were mixed together and 
incubated for 20 minutes at RT and gently mixed continuously.   
6. The culture medium was changed for fresh medium without P/S antibiotic content.  
7. The transfection mixture (Opti-MEM, Lipofectamine and DNA) was added to the 
cells.  
8. Cells were incubated at 37°C for 24 hours.  
9. The medium was change for fresh growing medium (with P/S). Optionally, selective 
antibiotics were added.  
 
PEI transfection  
1. Cells were seeded day before to be 60-70% confluent in the day of transfection, 
10cm dish size was normally used for transfection.  
2. Mix of 825 µl of sodium chloride water solution (150 mM) and 20 µg of DNA was 
prepared. 
3. Mix of 725 µl of sodium chloride water solution (150 mM) was mixed with 100 µl of 
PEI.  
4. Both mixtures were vortexed and incubated for 15 minutes at RT.  
5. Sodium chloride solution/PEI and sodium chloride solution/DNA mixtures were 
mixed together, vortexed and incubated for 10 minutes at RT.  
6. The culture medium was changed for only DMEM.  
7. The transfection mixture (sodium chloride solution, PEI and DNA) was added to cells. 
8. The cells were incubated for 2,5 hours at 37°C.  




10. The medium was changed for fresh growing medium without P/S antibiotic content. 
 
Retroviral transduction 
1. HEK Phoenix-Eco cells (10cm Petri dish) were used for retrovirus production – cells 
were transfected by Lipofectamine method with pBabe constructs (day 0). 
2. Day 2, culture medium of HEK cells was collected and centrifuged for 30 minutes and 
3800 g.  
3. The supernatant was transferred to the new tube and centrifuged for 30 minutes 
and 3800 g.  
4. The supernatant was mixed with 4µg/ml of polybrene (Millipore, ref. TR-1003-G) and 
HS (to final concentration 5%) and was added to the final cells (10cm dish). 
5.  The cells were incubated for 6 hours at 37°C.  
6. The culture medium was changed for fresh growing medium. 
7. The cells were incubated for 24 hours at 37°C.  
8. Specific dose of selective antibiotic was added.  
 
Lentiviral transduction 
1. HEK 293 RT cells (10cm Petri dish) were used for lentiviral production. Cells were co-
transfected by PEI method with pCMV-VSV-G, psPAX2 and pLentiCRISPR plasmids in 
ratio 1:1,5:2 in final of 20 µg of DNA (day 0).  
2. Day 2, culture medium was collected and centrifuged for 15 minutes and 3800 g. 
3. The supernatant was replaced to the new tube and PEG-it (SBI, ref. LV810A-1) was 
added to the final ratio 1:5.  
4. The mixture was incubated at 4°C for 16-18 hours, gently shaking constantly.   
5. The mixture was centrifuged for 30 minutes and 3800 g and the supernatant was 
discarded.  
6. The pellet was resuspended in 1 ml of PBS.  
7. Transduction mix (500 µl of viral solution with 500 µl of growing media) was added 
to the final cells (3cm dish).  
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8. The cells were incubated for 24 hours at 37°C.  
9. Culture medium was changed for fresh growing medium.  
10. The cells were incubated for 24 hours at 37°C.  
11. Specific dose of selective antibiotic was added.  
 
Cell fixation 
1. Culture medium was removed from the cells.  
2. The cells were washed with PBS.  
3. Paraformaldehyde (4%) was added to the cells and it was incubated for 15 minutes 
at 4°C.  
4. The cells were washed 3 times for 5 minutes with PBS at RT.  
5. Optionally stored in PBS at 4°C. 
 
Antibody staining 
1. Fixed cells were permeabilized by 0,1% Triton X-100 in PBS for 15 minutes at RT.  
2. The cells were washed 3 times for 5 minutes with PBS at RT.  
3. The blocking solution containing 2% NGS and 1% BSA in PBS was prepared and added 
to the cells. It was incubated for 1 hour at RT.  
4.  Primary antibody (in specific concentration) was diluted in 1% BSA in PBS and was 
added to the cells. It was incubated for 16-18 hours at 4°C.  
5. The cells were washed 3 times for 5 minutes with PBS at RT.  
6. Secondary antibody (1:1000) was diluted in 1% BSA solution in PBS (1x) and was 
added to the cells. It was incubated for 1 hour at RT – kept in dark.  
7. The cells were washed 3 times for 5 minutes with PBS at RT.  





Thymidine incorporation assay 
1. Cells were seeded into 96 well plate in three different concentrations and 3H-
Thymidine was added (8,54 ng in 125 µl of growing medium).  
2. The cells were cultivated for 8 hours at 37°C and then quickly frozen in -80°C.  
3. The cells were thawed and cell lysate was transferred to Printed Filtermat A 
membrane by Filtermat Harvester, the liquid was dried.  
4. MultiLex A gel was melted on the membrane and cooled down.  
5. The amount of incorporated 3H-Thymidine in the membrane was measured by 1450 
MicroBeta.  
 
Cell cycle measurement 
1. The cells were collected and centrifuged for 3 minutes and 120 g. The supernatant 
was removed. 
2. The cells were washed with PBS, centrifuged for 3 minutes and 120 g. The 
supernatant was removed.  
3. Single cell suspension was made in 0,5 ml of PBS.  
4. The cell suspension in PBS was slowly added to 4,5 ml of 70% ethanol at 4°C.  
5. The cell suspension was incubated at -20°C for 16-18 hours.  
6. The cell suspension was centrifuged for 7 minutes and 3800 g and the supernatant 
was removed.  
7. The cells were washed twice with PBS and centrifuged for 7 minutes and 3800 g, the 
supernatant was removed.  
8. Single cell suspension was made in 0,1 ml of PBS. 
9. Staining mix (90 µl of PBS 1x, 2 µl of 10% Triton X-1000, 4 µl of RNAse A, 10 mg/ml, 
and 4 µl of propidium iodid, 1 mg/ml) was prepared and added to the cell 
suspension.  
10. The cell suspension was incubated for 15 minutes at 37°C.  
11. The cell cycle was measured by LSR II flow cytometer (BD Biosciences) and data were 
evaluated by FlowJo 8.8.6 software.  
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3.2.4 Protein work 
Protein isolation 
1. The cells were dispersed into 1 ml of PBS, centrifuged for 3 minutes and 2500 rpm 
(Eppendorf 5415R) and the supernatant was removed. 
2. The pellet was resuspended in 200 µl of SB buffer and incubated for 5 minutes at 
95°C.  
3. The mixture was twice sonicated for 20 seconds. 
4. The mix was centrifuged for 5 minutes and 13 000 rpm.  
5. The bromphenol blue dye was added and sample was used for SDS-PAGE, eventually 
stored at -80°C.  
 
SDS-PAGE 
Precast gradient 4-15% polyacrylamide gel (Biorad) were used for protein separation. The 
protein samples were loaded on the gel and 1x TGS buffer was used as running buffer. 




Separated protein samples were transferred to the nitrocellulose membrane. As running 
buffer, 1x TG buffer was used and 100 V were set up for 1 hour. The blotting buffer was 
cooled down during whole procedure by addition of ice bucket.  
 
Immunostaining of western blot 
1. The membrane was first blocked by 5% non-fat milk solution in TBST buffer for 20 
minutes.  
2. The membrane was washed with TBST. 
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3. Primary antibody was diluted in 1% non-fat milk solution in TBST buffer and added to 
the membrane and incubated for 16-18 hours at RT.  
4. The membrane was washed with TBST.  
5. Secondary antibody was added and incubated for 2 hours.  
6. The membrane was washed with TBST. 
7.  ECL reagents (in 1:1 ratio of volume) were added to the membrane, incubated for 3 
minutes.  
8. The membrane was exposed to medical X-ray film and developed by Kodak 
developing machine.  
 
3.2.5 Statistical analysis 
Paired t-test was used to analyse statistics of selected experiments. All analysis was 
performed by GraphPad Prism® 5.0c. Asterisks in graphs indicate: * P ˂ 0,05, ** P ˂ 0,01, 





4. 1 DISP3 overexpression 
First, we started to ask for cell line suitable for both DISP3 overexpression and knock-out 
experiments. As DISP3 is expressed mainly in the neural tissue and the retina, we chose 
several human cell lines of neural and retinal origin, which we had in our depository. D341, 
D425 and DAOY medulloblastoma cell lines were chosen as well as Y79 retinoblastoma cell 
line. Moreover, we also decided to look for DISP3 expression in MCF-7, breast cancer cell 
line. As a control for normalization we used HEK 293 cells. We performed qRT-PCR to 
measure DISP3 expression on mRNA level (Figure 4.1).  
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We showed, that expression in distinct medulloblastoma cell lines varied. D341 and D425 
cell lines reveal increased DISP3 expression compared to HEK cells, when DISP3 expression 
in DAOY cells was low. Retinoblastoma cell line, Y79, showed enormous increase in DISP3 
expression, when compared to HEK cells. Finally, breast cancer MCF-7 cells showed very low 
expression (Figure 4.1).  
 
Distinct medulloblastoma cell lines reveal different level of DISP3 expression, which makes 
them suitable for overexpression and knock-out studies. We decided to use DAOY cells, with 
low expression of DISP3 for over-expression studies and D341 cell line with significantly 
increased level of DISP3 expression for knock-out experiments.  
We transfected DAOY cells with pCDNA3 – DISP3 construct expressing human DISP3 and as 
a control we used empty pCDNA3 vector. After transfection, we selected DAOY cells by 
addition of G418. DISP3 expression was concomitantly proved by RT-PCR (Figure 4.2).  
 
Figure 4.1. The graph shows DISP3 expresion in D341, D425, DAOY, HEK293, MCF-7 and 
Y79 cell lines analysed by qRT-PCR. The data were normalized to HEK293 cell line. Error 
bars represents standard deviation of three independent experiments.  
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When we obtained pCDNA3 and pCDNA3 – DISP3 stable cell cultures, we performed 3H-
Thymidine incorporation assay to analyse effect of DISP3 overexpression on proliferation of 
DAOY cells (Figure 4.3). Cells ectopically expressing DISP3 reveals almost 2-fold increased 
proliferation compared to control cells. These data shows, that DISP3 ectopic expression 
promotes DAOY cells proliferation.  
 
It was shown that distinct subtype of medulloblastoma may arise within neural progenitor 
subpopulation (Schuller, Heine et al. 2008, Yang, Ellis et al. 2008). Moreover, 
medulloblastoma tumors contain cells with stem cell properties still capable to differentiate 
(Hemmati, Nakano et al. 2003). Based on these findings, we asked, whether DISP3 
expression may also affect cell differentiation. Here, we use mouse neural progenitor cell 
line C 17.2, derived from the cerebellum (Snyder, Deitcher et al. 1992), which was shown to 
be capable of differentiation to neurons and astrocytes (Lundqvist, El Andaloussi-Lilja et al. 
2013), to study the impact of overexpression of DISP3 on cell differentiation.  
  
 
Figure 4.2. The picture shows DISP3 expression in DAOY cells transfecetd with pCDNA3-
DISP3 construct, cells with empty pCDNA3 vector are used as a control. Expression was 





Figure 4.3. The graph shows 3H-Thymidine incorporation in DAOY pCDNA3 and pCDNA3-
DISP3 transfecetd cells. The data were normalized to pCDNA3 transfected cells. Error 
bars represents standard deviation.  
 
 
Figure 4.4. The picture shows DISP3 expression in pBabe-Hygro and pBabe-Hygro-DISP3 




We generated C 17.2 with DISP3 ectopic expression by retroviral transduction of pBabe – 
Hygro – DISP3 construct, empty pBabe – DISP3 vector was used as a control. We added 
hygromycin to obtain DISP3 stably expressing cells and confirmed the expression by RT – 
PCR (Figure 4.4), immunoblotting (Figure 4.5) and by immunofluorescence (Figure 4.6). 
 
 
Figure 4.6. The picture shows immunofluorescence staining of pBabe-Hygro and pBabe-
Hygro-DISP3 transduced C 17.2 cells with DISP3 antibody. DAPI staining was used for 
visualization of cell nuclei. Bar indicates 50 µm.  
 
 
Figure 4.5. The picture shows DISP3 expression in pBabe-Hygro and pBabe-Hygro-DISP3 
transduced C 17.2 cells. Expression was analysed by western blotting and GAPDH was 
used as a loading control.  
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With pBabe – Hygro – DISP3 stable C 17.2 cells we performed 3H – Thymidine incorporation 
assay to measure DISP3 effect on the proliferation as well as we did with DAOY cell line. 
DISP3 ectopically expressing C 17.2 cells revealed 1.7 – fold increased proliferation 
compared to control cells (Figure 4.7). This proves the result we obtained with DAOY cells.  
Next, we performed differentiation experiment with C 17.2 cells transduced by pBabe – 
Hygro - DISP3 construct, as a control we used an empty vector. We differentiated C 17.2 
cells according to protocol of Lundqvist et. al. (Lundqvist, El Andaloussi-Lilja et al. 2013). 
Under these conditions, C 17.2 cells are capable of differentiation into mixed population of 
neurons and astrocytes within 7 days, when cultured with N2 supplement, BDNF and NGF.  
 
 
Figure 4.7. The graph shows 3H-Thymidine incorporation in pBabe-Hygro and pBabe-
Hygro-DISP3 transduced C 17.2 cells. The data were normalized to pBabe-Hygro 
transduced cells. Error bars represents standard deviation. 
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Upon differentiation conditions we observed morphological changes in both DISP3 
expressing and control cells. While C 17.2 cells cultured under growing conditions showed 
polygonal morphology, differentiated cells showed neuron-like protrusions. 
 In control cells, we observed first protruded shapes at the day 5 of treatment and at the 
day 7 cells showed final differentiated shape. C 17.2 cells with DISP3 ectopic expression 
showed different behaviour compared to control cells.  At the day 5 of treatment, they 
showed only slightly protruded shape, at the day 7 most of cells were protruded, however, 
neuron-like shape was not observed (Figure 4.8). These data show that cells with DISP3 
ectopic expression undergo morphological changes later than controls.  
To analyse differentiation of C 17.2 cells, we collected cell samples at the day 0, 1, 2, 3, 5 
and 7 of differentiation and performed qRT-PCR (Figure 4.9a, b, c) and immunofluorescence 
microscopy (Figure 4.10, 4.11 and 4.12) of cell subtype specific markers. We used Nestin as 
a marker of neural progenitor, βIII-tubulin as a marker of neuronal and GFAP as a marker of 
astrocytic differentiation. 
Upon differentiation conditions, we observed expected decrease of Nestin mRNA in both 
control and DISP3 ectopically expressing cells, as cells were losing their progenitor 
properties. At the day 1 and 2 of differentiation, cells ectopically expressing DISP3 revealed 
significantly higher level of Nestin mRNA, which was not observed at the day 3 or later 
(Figure 4.9a).  We also stained our cells with Nestin specific antibody to observe this marker 
on protein level. Expression of Nestin protein was high in both DISP3 expressing and control 
cells, however, at the day 2 of differentiation, DISP3 expressing cells showed significant 
increase in Nestin antibody staining compared to control (Figure 4.10). 
Next, we observed huge variations of βIII-tubulin mRNA levels during differentiation period. 
The main increase of βIII-tubulin expression was observed between days 2 – 5, and then the 
expression slightly decreased. However, during all the differentiation period, we observed 
significantly lower level of βIII-tubulin mRNA expression in DISP3 expressing cells compared 
to control (Figure 4.9b). When we performed βIII-tubulin antibody staining, cells with DISP3 
ectopic expression revealed less staining than control already at the initial day of 
differentiation. At the day 7, cells ectopically expressing DISP3 showed significantly less βIII-
tubulin than control cells. Also, βIII-tubulin positive cells in both cultures showed huge 
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difference in morphology. In control cells, they revealed neuron – like shape. This result was 
not observed, when cells expressed DISP3 (Figure 4.11). 
Finally, we analysed GFAP expression. At the initial day of differentiation, both DISP3 
expressing and control cells showed very low GFAP expression on qRT – PCR, while after 3 
days of treatment expression was rapidly increasing until the end of differentiation. GFAP 
expression in DISP3 expressing cells remained lower during the whole differentiation period 
compared to control cells (Figure 4.9c).   
 
Figure 4.8. The picture shows pBabe-Hygro and pBabe-Hygro-DISP3 transduced C 17.2 





Figure 4.9b. The graph shows the expression of βIII-tubulin marker. The expression was 
analysed by qRT-PCR and normalized to pBabe-Hygro C 17.2 cells. Error bars represent 
standard deviation. 
 
Figure 4.9a. The graph shows expression of Nestin markers. The expression was analysed 





These results were consistent with GFAP specific antibody staining where we observed very 
low expression of GFAP in both DISP3 expressing and control cells at the day 0. After 7 days 
of differentiation, GFAP protein level increased while it was significantly lower in DISP3 
ectopically expressing cells compared to control (Figure 4.12). 
All the data show that ectopic DISP3 expression promotes delay in C 17.2 cell differentiation 
as it is apparent on neuronal and astrocytic marker levels as well as on morphological 
changes. Both GFAP and βIII-tubulin reveal lower expression in DISP3 expressing cells while 
Nestin, as a marker of neural progenitor, reveals higher expression in the initiation of 
differentiation process. Together with higher proliferative rate of DISP3 expressing C 17.2 
and DAOY cells, our experiments suggest DISP3 role in regulation of cell fate decision within 
cells of neural origin. 
 
 
Figure 4.9c. The graph shows expression of GFAP marker. The expression was analysed 






Figure 4.10. The picture shows immunofluorescence staining of pBabe-Hygro and pBabe-
Hygro-DISP3 transduced C 17.2 cells with Nestin antibody. DAPI staining was used for 







Figure 4.11. The picture shows immunifluorescence staining of pBabe-Hygro and pBabe-
Hygro-DISP3 transduced C 17.2 cells again βIII-tubulin protein. DAPI staining was used 







Figure 4.12. The picture shows immunofluorescnece staining of pBabe-Hygro and pBabe-
Hygro-DISP3 transduced C 17.2 cells with GFAP antibody. DAPI staining was used for 
visualization of cell nuclei. Bar indicates 50 µm.  
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4.2 DISP3 targeting 
Next, we wanted to analyse whether lack of DISP3 expression has effect on cell 
proliferation. For this purpose, we decided to use D341 cells as we showed that DISP3 
expression is high in this cell line (Figure 4.1). Moreover, these cells have human 
medulloblastoma origin same as DAOY cells, which we used for the overexpression 
experiment.  
 First, we chose CRISPR target sequences in DISP3 gene to mutate six different sites. All the 
sites were targeted into exons of the gene – Loop 1.1, Loop 1.2 and Loop 1.3 target sites 
were found in the second exon, Loop 1.4 target site was found in the third exon, SSD4 target 
site was found in the fourth exon and finally SSD5 target site was found in the fifth exon. All 
the sites of predicted mutations lay within the first third of DISP3 transcript and were 
chosen with the respect to the protein structure - Loop CRISPR sites target first luminal loop 
of DISP3 and SSD CRISPR sites target SSD domain of DISP3 protein (Figure 4.13). 
 
In this knock-out experiment we used CRISPR-Cas9 lentiviral transduction system to perform 
sequence specific frameshift mutations (Shalem, Sanjana et al. 2014). We prepared 
pLentiCRISPR constructs encoding each Loop1.1, Loop1.2, Loop1.3, Loop1.4, SSD4 and SSD5 
specific CRISPR gRNA.  
 
Figure 4.13. The scheme indicates sites of individual CRISPR targets within both DISP3 
gene and protein.  
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At the beginning, we transfected HEK 293 FT cells with individual pLentiCRISPR constructs to 
analyse gRNA efficiency. For analysis of desired regions of genomic DNA, we performed PCR 
of the CRISPR target genomic regions and then we subcloned and sequenced the reaction 
product. Under alignment, we observed mutations within target sequences of individual 
CRISPRs (Figure 4.14). At the Loop 1.1, Loop 1.2 and SSD4 cutting sites we observed huge 
deletions in all of the sequenced samples, suggesting that CRISPR efficiency in these cases 
was high. At the Loop 1.4, we observed both deletion and insertion mutations as well as 
non - mutated sequences, suggesting that CRISPR Loop 1.4 is also efficient (Figure 4.14). At 
the Loop 1.3 cutting site there were no mutations. Unfortunately, we did not confirm SSD5 
cutting site as we were not able to obtain specific PCR product. Therefore, we decided to 
use pLentiCRISPR - Loop 1.1, Loop 1.2, Loop 1.4 and SSD4 constructs in our experiments.  
Next, we transduced D341 cells with chosen pLentiCRISPR viruses and used T7 endonuclease 
assay to analyse whether transduced cells also bear DISP3 gene mutations. All our 
transductions were functional and our CRISPRs specifically introduced mutations which we 
proved by T7 endonuclease assay (Figure 4.15).  
 
Figure 4.15. The picture shows analysis of mutations within individual CRISPR target sites 
in  pLentiCRISPRs transduced D341 cells. Mutations were analysed by T7 endonuclease 
assay, NC indicates negative control - D341 cells transduced by empty vector, PC 





Figure 4.14. The scheme shows sequencing analysis of CRISPR target sites within 
individual pLentiCRISPRs transduced HEK293FT cells. Red bars indicates exptected 
CRISPR cutting site. PAM sequence is indicated by red colour.  
65 
 
Next we performed qRT-PCR to analyse DISP3 expression in DISP3 mutated D341 cells, 
empty pLentiCRISPR vector was used as a control. We observed lower expression in all of 
the DISP3 mutated cultures. DISP3 expression was 0,7 - fold lower in Loop 1.1 cell culture, 
0,8 – fold lower in Loop 1.2 cell culture, 0,7 – fold lower in Loop 1.4 cell culture and 0,5 – 
fold lower in SSD4 cell culture (Figure 4.16). 
 
When we proved that DISP3 mutations also diminished DISP3 expression level. We 
continued with proliferation measurement. We performed 3H – Thymidine incorporation 
experiment with all of the variants of DISP3 mutated cells and we used cells transduced with 
empty pLentiCRISPR vector as a control. We observed significantly lower incorporation in 
most of our mutated cell cultures (Figure 4.17). 
 
Figure 4.16. The graph shows DISP3 expression within individual pLentiCRISPRs 
transduced D341 cells. The data were normalized to D341 cells transduced by empty 
vector. Error bars represent standard deviation.  
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The cell culture with Loop 1.1 induced mutations revealed 0,8 – fold lower thymidine 
incorporation compared to a control as well as Loop 1.2 induced mutation cell culture. The 
cell culture with Loop 1.4 induced mutation showed 0,7 – fold decrease in thymidine 
incorporation compared to a control. However, cells with the last and most downstream, 
SSD4 induced mutated site revealed no changes in thymidine incorporation (Figure 4.17).   
 
Finally, when we observed that cells with more upstream DISP3 mutations have significantly 
lower proliferation rate, we started to ask whether these cells also differ in their cell cycle 
profile. Thus, we stained D341 cells with individual DISP3 mutations with propidium iodide 
and analysed them by flow cytometry, cells transduced by empty pLentiCRISPR vector were 
used as a control (Figure 4.18).  
 
Figure 4.17. The graph shows 3H-Thymidine incorporation in individual pLentiCRISPRs 
transduced D341 cells. The data were normalized to D341 cell transduced by empty 




We observed a common cell cycle profile in our control cells, where most of the cells were 
in the G1 phase – specifically it was 50 % of control cells. The second most abundant cell 
phase was S phase, where we observed 44 % of control cells. The minority of cells stayed 
within G2 phase, in our case it was 6 % of the cells.  
When we compared the cell cycle profile of our DISP3 – mutated cells, we did not observe 
any notable changes in their profile in the case of Loop 1.2, Loop 1.4 and SSD4 mutations. 
However, in the case of most upstream Loop 1.1 mutation we observed a difference in the 
cell cycle profile compared to control - 59 % cells were in G1 phase and in consistency with 
that only 36 % of cells were in S phase.  
 
Figure 4.18. The graph shows cell cycle profile of D341 cells transduced by chosen 




In this thesis we study role of DISP3 in cell proliferation. First, we confirmed DISP3 
predominant expression in human medulloblastoma and retinoblastoma cell lines, which is 
in consistency with previous findings that DISP3 is mainly expressed in neural and retinal 
tissues (Zikova, Corlett et al. 2009). In human medulloblastoma we observed increased 
expression in D341 and D425 cell lines. In contrast, DAOY cell line showed very low level of 
DISP3 expression. These findings made D341 and DAOY medulloblastoma cell lines suitable 
for knock-out and overexpression studies.  
Medulloblastoma is a highly common and malignant pediatric brain tumour, arising within 
cerebellum. It is subdivided into 4 subgroups according to its molecular biology background 
– SHH, WNT, 3 and 4, where the third and fourth subgroups are not very well characterized. 
Our ArrayExpress analysis of several datasets revealed significant increase in DISP3 
expression within all subgroups of medulloblastoma, when compared to normal adult 
cerebellum and other brain tumours. Comparing each medulloblastoma subgroups, DISP3 
was predominantly expressed within subgroup 4. This finding is in consistency with our 
previous observation, where we used qRT-PCR and immunohistochemistry staining to 
analyse our set of medulloblastoma patient samples (preliminary data, not published, Figure 
2.4).  
Although our immunohistochemical analysis contained only limited number of samples, 
together with the data from ArrayExpress analysis strongly suggests that DISP3 plays role in 
medulloblastoma tumours properties and, after further evidence, may serve as a marker for 
medulloblastoma subgroup 4.  
Furthermore, we wanted to analyse what role DISP3 expression may play in tumour 
properties of medulloblastoma. As increased cell proliferation is a major sign of cancer cells, 
we first started to ask whether DISP3 expression affects cell proliferation. In our study we 
used DAOY cells to overexpress DISP3 and measured 3H-Thymidine incorporation. We 
observed 2-fold increase of 3H-Thymidine incorporation in DISP3 expressing cells compared 
to theby asymmetrical division control. These data suggest that DISP3 may affect cell 
properties inducing its proliferation.  
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To prove our findings, we used C 17.2 mouse neural progenitor cell line with low expression 
of DISP3 to perform another overexpression experiment. The C 17.2 cell line was derived 
from EGL zone of mouse cerebellum and keeps part of its properties also in vitro, as it is 
capable of differentiation into neurons and astrocytes (Snyder, Deitcher et al. 1992, 
Lundqvist, El Andaloussi-Lilja et al. 2013). EGL zone of cerebellum is part of the brain where 
neural progenitors undergo massive proliferation and afterwards they differentiate into 
neurons and glia. It was shown that dysregulation of this process may lead to cancer 
progression and medulloblastoma formation (Schuller, Heine et al. 2008). This background 
makes C 17.2 cells a very good model for studies of medulloblastoma formation. Here we 
show that overexpression of DISP3 within C 17.2 cells promotes their proliferation as we 
observed 1,7-fold increase of 3H- Thymidine incorporation within C 17.2 cells expressing 
DISP3 in comparison to the control. These data thus proved our observation within DAOY 
cells and suggests, that overexpression of DISP3 plays role in medulloblastoma cancer 
progression.  
As it was shown that some medulloblastoma arise from neural progenitors (Schuller, Heine 
et al. 2008, Yang, Ellis et al. 2008) and also medulloblastoma itself reveals stem-like 
properties (Hemmati, Nakano et al. 2003), we wanted to analyse whether DISP3 
overexpression affects this ability. We overexpressed DISP3 in C 17.2 cells and analysed 
their ability to differentiate into neurons and astrocytes. Upon differentiation conditions, 
we observed morphological changes of control cells earlier then in DISP3 expressing cells 
and morphology of both cells was still different at the end of the differentiation period. 
These observations suggest that DISP3 expression leads to delay in differentiation and this 
process could be accompanied by its higher proliferation as we measured before.  
We proved that C 17.2 cells differentiated into neurons and astrocytes, as we measured 
increase in βIII-tubulin and GFAP expression and expected decrease in Nestin expression. 
Delay in differentiation of DISP3 expressing C 17.2 cells was apparent in all of the three 
markers. At the beginning of differentiation, Nestin expression was higher in DISP3 
expressing cells compared to the control and this difference then gradually decreased, in 
the end of differentiation period Nestin expression became the same in both cells. These 




Similar result was shown when we analysed GFAP expression. C 17.2 cells with DISP3 
expression revealed less GFAP expression during whole differentiation when compared to 
control cells. When we analysed βIII-tubulin expression, we observed that DISP3 expressing 
cells followed the expression pattern of control cells, however, βIII-tubulin expression was 
significantly lower in all stages of the differentiation period.  
Together, these data show that C 17.2 cells with DISP3 ectopic expression undergo neuronal 
and glial differentiation more slowly than control cells but DISP3 expression itself is not 
sufficient to block the differentiation completely. In context of neurodevelopmental origin 
of distinct medulloblastoma, all these data suggest that DISP3 dysregulated expression may 
play role in medulloblastoma formation, as it promotes cell proliferation and delays its 
differentiation.  
Consequently, we asked whether also lack of DISP3 expression will lead to diminished 
proliferation and thus negatively affect cancerous properties of medulloblastoma cells. In 
our experiments we induced several mutations within DISP3 gene by CRISPR-Cas9 system in 
D341 medullublastoma cell line with increased expression of DISP3. Concomitantly, we 
analysed 3H-Thymidine incorporation similarly as in previous overexpression experiments 
and observed decrease in cell proliferation. When we induced DISP3 mutations within 
Loop1.1, Loop1.2 and Loop1.4 sites, proliferation rate was 0,7 – 0,8-fold lower than in 
control cells. In contrast, when we induced mutation within SSD4 site proliferation was not 
changed.  
Cell proliferation depends on the ability of the cell to get through the cell cycle and its 
checkpoints. Therefore, we asked whether DISP3 mutations have effect on this ability. We 
measured cell cycle profile of each DISP3 mutant cells and control cells. In the case of 
Loop1.1 mutation we observed that cells rather persisted within G1 phase. This may suggest 
that DISP3 Loop 1.1 mutation affect ability of D341 cells to pass the G1/S phase checkpoint. 
However, this ability was not affected by any other mutation sites, even if it was located 
within the first luminal loop.  
Possible reason for differences between each mutated cell cultures may be the mechanism 
of knock-out performed by CRISPR-Cas9 system. As Cas9 endonuclease induces 
doublestrand DNA breaks, we assumed that DNA repair mechanism represented by 
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non-homologous end joining (NHEJ) pathway will induce insertion or deletion mutations 
(Davis and Chen 2013). Although we confirmed the ability of our specific gRNAs to induce 
mutations in our experiments and used only capable guides, gene manipulation itself may 
not be sufficient for abortion of DISP3 expression. 
We assumed that frameshift caused by NHEJ pathway make premature stop codons and 
these will be then recognised and degraded by non-sense mediated decay pathway. 
However, efficiency of this process is not the same for all the transcripts and some of the 
premature stop codons may not be recognised at all (Lappalainen, Sammeth et al. 2013).  
To prove whether DISP3 transcript is getting degraded in our cells, we performed qRT-PCR 
and observed decrease in DISP3 expression within all of the versions of DISP3 mutations. 
Thus we concluded that all of our mutated transcripts are recognised by non-sense 
mediated decay and degraded and it probably does not cause observed difference in D341 
cell proliferation.  
Another possible reason might be that the rest of the present mutated DISP3 transcripts are 
still translated and produce aberrant, somehow more stable, protein forms. In this case, 
Loop1.1, Loop1.2 and Loop1.4 mutated D341 cells would produce short DISP3 protein with 
one transmembrane domain and different lengths of the first loop. However, in the case of 
SSD4 mutated D341 cells aberrant DISP3 protein would consist of the first transmembrane 
segment, intact luminal loop and part of SSD transmembrane domain. This may suggest, 
that protein domain responsible for the phenotype is localized within the first luminal loop, 
as proliferation is not affected only in the cells with intact luminal loop. However, to make 
this conclusion, we would need further evidence on protein expression.  
Next, as CRISPR-Cas9 system in our settings induce mutations randomly, cell culture after 
antibiotic selection still contains numerous mix of different DISP3 transcripts. To avoid that 
clonal selection of mutated cells would be necessary. However, our efforts to produce DISP3 
clonal mutants failed so far and we thus preformed our experiments within the cell mixture 
and that could also be the reason for slightly different results in the different mutated cell 
lines we used.  
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Moreover, in the case of CRISPR-Cas9 system mediated genome editing, there are 
controversies about off-target effects of gRNAs. These can also recognize sequences with 
several mismatches  (Lin, Cradick et al. 2014). This feature of CRISPR-Cas9 system can thus 
affect the phenotype and cause differences in our observations. Because off-target 
prediction tools were not available at the beginning of our experiment, we analysed our 
gRNAs retrospectively. We used Off-Spotter and analysed possible off-targets with up to 3 
mismatches (Pliatsika and Rigoutsos 2015). The amount of possible off-targets is luckily 
rather small, all of our gRNAs do not reveal any target sequences for 1 and 2 mismatches 
and in the case of 3 mismatches they reveal up to 13 off-targets with no overlaps. These 
findings suggest that our observations were not caused by off-target effect of CRISPR-Cas9 
system.  
Taken together, our data show that DISP3 affect cell proliferation of medulloblastoma cells 
in two ways. DISP3 overexpression leads to promotion of cell proliferation and DISP3 
diminished expression leads to decrease in cell proliferation. This suggests that DISP3 
increased expression in subgroup 4 medulloblastoma patients can have effect on tumour 
properties and progression.  
Moreover, microarray gene expression analysis of C 17.2 cells with DISP3 overexpression 
revealed EPB4.1L3 and PRELP genes, expression of which was significantly reduced (Zikova, 
Konirova et al. 2014). EPB4.1L3 is a member of a protein family involved in linking of 
transmembrane glycoproteins to actin cytoskeleton and thus affecting many cellular 
processes such as cell proliferation, polarization or migration. All these processes are 
involved in tumour progression and it was shown that in highly metastatic prostate cancer, 
Epb4.1l3 is reduced (Wong, Haack et al. 2007). Similarly, PRELP was found as counteracting 
factor in formation of bone and visceral metastasis formation in breast cancer (Rucci, Capulli 
et al. 2013). These data thus suggest that DISP3 expression in medulloblastoma affects also 







In this thesis, we focused on DISP3 role in cell proliferation in vitro. We generated DISP3 
stable ectopic expression within DAOY medulloblastoma cells and C 17.2 neural progenitor 
cells. We analysed DISP3 effect on cell proliferation and observed 2-fold increase in 
proliferation of DAOY, and 1,7-fold increase in proliferation of C 17.2 cells.  
Next, we analysed level of DISP3 expression in differentiation of C 17.2 cells into neurons 
and astrocytes. We applied successful differentiation conditions and observed both 
neuronal and astrocytic differentiation in control cells. C 17.2 cells with DISP3 ectopic 
expression showed delay in this process. This we confirmed by Nestin, βIII-tubulin and GFAP 
analysis using qRT-PCR and immunofluorescence staining.  
Further, we analysed DISP3 gene and chose 6 possible CRISPR target sequences within 
several exons. We cloned pLentiCRISPR constructs encoding Cas9 endonuclease and 
individual gRNA that targets chosen sequences. Cutting efficiency of individual constructs, 
we then confirmed by sequencing of target sites. Next, we used four efficient pLentiCRISPR 
constructs to generate DISP3 mutations in the D341 medulloblastoma cell line within 4 
different sites. Successful mutagenesis we proved by T7 endonuclease assay.  
Finally, we analysed cell proliferation of individual DISP3 mutants and observed 0,7- to 0,8 - 
fold diminished cell proliferation within three of four mutated cell cultures. Moreover, we 
analysed cell cycle profile of individual DISP3 mutants. Only one of four mutated sites 
demonstrated changes in the profile showing that cells rather persisted in G1 phase.  
Taken together, our data show that DISP3 ectopic expression promotes cell proliferation 
and leads to a delay in neural differentiation. Similarly, DISP3 reduced expression leads to 
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